Delving into the Latest Updates on BC0306 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms

Target-

Mechanism-

Therapeutic Areas

Digestive System Disorders

Active Indication

Nonalcoholic Steatohepatitis

Inactive Indication-

Originator Organization

Shandong Danhong Pharmaceutical Co., Ltd.

Active Organization

Shandong Danhong Pharmaceutical Co., Ltd.

Inactive Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

The primary objective is to evaluate the safety and tolerability of BC0306 after a single dose in healthy adults on an empty stomach. The secondary objective is to evaluate the pharmacokinetic/pharmacodynamic characteristics of BC0306 after a single dose in healthy adults on an empty stomach. The secondary objective is to explore the possible metabolites of BC0306 capsules after oral administration of a specific dose.

Start Date11 Jul 2024

Sponsor / Collaborator

Shandong Danhong Pharmaceutical Co., Ltd.

100 Clinical Results associated with BC0306

Login to view more data

100 Translational Medicine associated with BC0306

Login to view more data

100 Patents (Medical) associated with BC0306

Login to view more data

100 Deals associated with BC0306

Login to view more data